Navigation Links
Remote ICD monitoring a 'safe alternative' to conventional follow up
Date:8/29/2011

Device management using a home monitoring system with daily telemetry in patients with ICDs (implantable cardioverter defibrilators) is a safe alternative to conventional monitoring and could decrease the number of inappropriate shocks, according to results of the ECOST study, a multicentre randomised trial performed in France.

The implantation of cardioverter defibrillators has now become standard practice for the prevention of sudden cardiac death in patients with heart rhythm disturbances; around 600 ICDs per million population are implanted yearly in the USA and 189 per million in Europe. The ECOST study was designed to investigate whether long-term daily remote monitoring using the Home Monitoring system is a safe option in comparison to in-clinic follow-up in ICD recipients.

"The information and communication technologies of e-health will radically change our healthcare systems over the next decade," said investigator Professor Salem Kacet from the Regional University Hospital of Lille, France. "This large multicentre trial aimed to demonstrate if a telemedicine system was as safe and efficient as conventional in-hospital monitoring and follow-up."

Long-distance implant telemetry allows the trend and event-triggered transmission of implant data and intra-cardiac ECG over distances of several metres, which are received by a patient device and subsequently transferred via a service centre to the physician on a password-secured internet site. Thus, the physician receives diagnostic information without the patient having to visit the physician.

The ECOST study followed-up a total of 433 patients for 27 months in 43 centres in France; patients were randomised to remote monitoring (active group) or in-clinic follow-up (control group). A first in-clinic ICD follow-up within 1-3 months after implantation was scheduled for all patients. Thereafter, patients in the active group were seen in the ambulatory department only once a year, unless an anomalous ICD function or event of clinical concern was reported by the remote monitoring system and required an additional in-clinic visit. In the control group patients were followed-up in the ambulatory department at six-month intervals.

Results showed according to the non-inferiority criteria of the trial that remote ICD monitoring is a safe alternative to conventional follow-up in terms of all cardiac and device-related major adverse events and all cause mortality. "These results are consistent with, and extend, previous findings by demonstrating the safety of long-term remote ICD monitoring," said Professor Kacet.

The ECOST trial was also the first to show a 52% reduction in the number of patients with inappropriate shocks and a 72% reduction in the risk of hospitalisations related to inappropriate shocks. In addition, results showed a 76% reduction in the risk of charged shocks, with a significant impact on ICD battery longevity. "This could have an interesting economic impact," said Professor Kacet, "by allowing ICD replacement at a later time." The effects of remote monitoring on the cost of health for ICD recipients will be evaluated in a forthcoming analysis.


'/>"/>

Contact: Jacqueline Partarrieu
press@escardio.org
33-633-473-335
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. Army Awards Remote Medical Coding Contract to DOMA Technologies
2. With magnetic nanoparticles, scientists remotely control neurons and animal behavior
3. Telementoring may address need for surgical subspecialty expertise in remote locations
4. Potential benefits of remote follow-up of ICD patients
5. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
6. ANT+ and iTMP Announce the Digifit™ Ecosystem - The First iPhone™ Apps to Integrate Running, Cycling and Heart Rate Monitoring
7. The Results Are In: Users of BodyMedia's Wearable Body-Monitoring Technology Lose 3 Times More Weight
8. Improved patient care with telemonitoring
9. IESO, one of the Independent System Operators in North America, Selects MetricStream GRC for Monitoring Compliance to Electric Reliability Standards
10. Six Degrees Launches ePulse - an Online Buzz Monitoring Tool
11. Revenues from Mobile Health Monitoring to Reach $1.9 Billion Globally by 2014 Says Juniper Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance Group, a ... communities across North Carolina, is launching a charity event in conjunction with the ... the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy Network (BCAN) ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Donna Bergman, professor of ... and published an article in the medical science journal Physical Medicine and Rehabilitation ... article and the research that helped produce it, were written and conducted in ...
(Date:7/25/2017)... WI (PRWEB) , ... July 25, 2017 , ... ... Aloria Health, as medical director. Dr. Negrette has more than a decade of ... She has worked closely with individuals fighting addictions, eating disorders, psychotic and manic ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... Product Innovation in the prestigious CEO World Awards®. The coveted annual CEO World ... and services, CEO case studies, corporate social responsibility, and milestones from every major ...
(Date:7/24/2017)... PARK (PRWEB) , ... July 24, 2017 , ... Engineers ... is bio-compatible, because it produces the same kind of electrical energy that the body ... the form of moving electrons. This flow of electrons out of the battery is ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
Breaking Medicine Technology: